Stemtech Corporation
STEK · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $5,054 | $4,922 | $4,559 | $4,321 |
| % Growth | 2.7% | 7.9% | 5.5% | – |
| Cost of Goods Sold | $1,326 | $1,002 | $1,164 | $1,023 |
| Gross Profit | $3,727 | $3,920 | $3,395 | $3,298 |
| % Margin | 73.8% | 79.6% | 74.5% | 76.3% |
| R&D Expenses | $0 | $14 | $0 | $0 |
| G&A Expenses | $5,234 | $6,440 | $6,838 | $4,754 |
| SG&A Expenses | $5,333 | $6,944 | $8,419 | $6,508 |
| Sales & Mktg Exp. | $99 | $504 | $1,581 | $1,755 |
| Other Operating Expenses | $781 | $1,187 | $8 | $0 |
| Operating Expenses | $6,114 | $8,144 | $8,419 | $6,508 |
| Operating Income | -$2,386 | -$4,225 | -$5,023 | -$3,210 |
| % Margin | -47.2% | -85.8% | -110.2% | -74.3% |
| Other Income/Exp. Net | -$1,386 | -$1,207 | -$3,514 | -$3,901 |
| Pre-Tax Income | -$3,773 | -$5,432 | -$8,537 | -$7,111 |
| Tax Expense | $0 | $0 | $96 | $0 |
| Net Income | -$3,770 | -$5,430 | -$8,633 | -$15,284 |
| % Margin | -74.6% | -110.3% | -189.3% | -353.7% |
| EPS | -0.032 | -0.065 | -0.19 | -0.41 |
| % Growth | 51.2% | 65.7% | 53.7% | – |
| EPS Diluted | -0.032 | -0.065 | -0.19 | -0.41 |
| Weighted Avg Shares Out | 118,698 | 83,470 | 44,974 | 37,616 |
| Weighted Avg Shares Out Dil | 118,698 | 83,470 | 46,014 | 37,616 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,579 | $4,893 | $4,098 | $8,330 |
| Depreciation & Amortization | $415 | $588 | $447 | $326 |
| EBITDA | -$1,778 | $49 | -$3,992 | $1,545 |
| % Margin | -35.2% | 1% | -87.6% | 35.8% |